$NASDAQ:SYNH

Syneos Health Intrinsic Stock Value – SYNEOS HEALTH Reports Slight Increase of 0.4% in Total Revenue for Q2 of 2023

☀️Earnings Overview On August 9, 2023, SYNEOS HEALTH ($NASDAQ:SYNH) released its financial results for the second quarter ended June 30, [...]

OLD Mission Capital LLC Invests in Syneos Health, During 4th Quarter

🌥️Trending News Syneos Health ($NASDAQ:SYNH) is a global biopharmaceutical solutions organization. It provides comprehensive end-to-end clinical and commercial solutions to [...]

SYNEOS HEALTH INC. (SYNH) Reports Q1 Revenue of $1.36B, Beating Street Estimate of $1.282B

🌧️Trending News SYNEOS HEALTH ($NASDAQ:SYNH) INC. (SYNH) is a leading global biopharmaceutical solutions organization, providing integrated services across the product [...]

By |June 18, 2023|Categories: Diagnostics & Research|Tags: , , |0 Comments

Syneos Health Intrinsic Value – FivepHusion and Treehill Partners Partner with Syneos Health to Advance Healthcare Solutions

Trending News ☀️ Syneos Health ($NASDAQ:SYNH) is an American multinational biopharmaceutical solutions company that focuses on helping biopharmaceutical and medical [...]

Syneos Health Stock Fair Value – Syneos Health Reports Record-Breaking Earnings and Revenue

Trending News 🌥️ Syneos Health ($NASDAQ:SYNH), a biopharmaceutical solutions company, recently reported record-breaking earnings and revenues. Non-GAAP Earnings Per Share [...]

By |May 11, 2023|Categories: Diagnostics & Research|Tags: , , |0 Comments

Syneos Health Launches Serplulimab, Introducing Comprehensive Commercialization Model for Healthcare Professionals and Patients

Trending News ☀️ Syneos Health ($NASDAQ:SYNH) is a global biopharmaceutical solutions organization that provides comprehensive commercialization services for healthcare professionals [...]

By |January 31, 2023|Categories: Diagnostics & Research|Tags: , , |0 Comments
Go to Top